← FDA Drug Approvals (Drugs@FDA)
MAXZIDE-25
NDA · New Drug Application · Sponsor: AUROBINDO PHARMA USA · Approved 1984-10-22
Drug application
- FDA Application #
NDA019129- Application type
- New Drug Application
- Brand name
- MAXZIDE-25
- Generic name
- Hydrochlorothiazide
- Active ingredients
- HYDROCHLOROTHIAZIDE; TRIAMTERENE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AUROBINDO PHARMA USA
- First approval
- 1984-10-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown